<?xml version="1.0" encoding="UTF-8"?>
<p>Motivated by the aforementioned facts, herein we have designed and prepared two series of novel chalcones substituted with trifluoromethyl (series-A) and trifluoromethoxy (series-B) groups (
 <xref ref-type="fig" rid="pharmaceuticals-13-00375-f003">Figure 3</xref>) and evaluated further for their antibacterial and antifungal activities against selected clinically significant bacterial and fungal strains.
</p>
